Latest North America News

Pro Medicus' U.S. subsidiary Visage Imaging has extended its contract with The Ohio State University Wexner Medical Center for five years, adding new Visage 7 modules and increasing transaction fees, underpinning strong client retention and platform demand.

Blue Star Helium has secured a three-month helium offtake agreement with a major US industrial gases player, establishing a cash flow foundation as it advances longer-term contracts and CO2 commercialisation.

Lithium Universe (ASX: LU7) has launched a detailed development program to commercialise a novel hydrometallurgical process for extracting gold and copper from electronic waste, aiming to disrupt traditional smelting with a more sustainable, low-energy method.

Corporate Travel Management reports progress on UK customer remediation with funding plans underway and final agreements near completion. The company maintains strong client retention above 97% and aims to release audited FY25 and reviewed 1H26 financials by end of June, eyeing a swift return to ASX trading.

4DMedical has leapfrogged into the European lung health market by acquiring Austrian AI imaging firm contextflow, gaining immediate commercial presence and a CE-marked lung cancer screening solution.

Barton Gold has raised $25.5 million through an institutional placement, fully funding critical feasibility studies and resource upgrades across its Challenger, Tunkillia, and Tolmer projects in South Australia.

Harvest Technology Group has appointed Veronica Bainton as CEO, signalling a sharpened focus on defence markets and scaling its Nodestream platform internationally.

Advanced Energy Minerals (ASX:AEM) is ramping up its Cap-Chat high purity alumina production, targeting 3,000 tpa by mid-2026 and planning to double capacity to 6,000 tpa by 2029 amid a forecast supply deficit and surging demand.

EcoGraf confirms its patented HFfree process offers competitive costs for producing high-purity spherical graphite, targeting non-Chinese battery supply chains with plans for facilities in the US, Europe, and Asia.

ikeGPS Group delivered a strong FY26 with platform subscription revenue up 33% to NZ$19.2 million and positive underlying EBITDA in March, supported by AI-driven pricing and expanding US utility adoption.

FirstWave Cloud Technology posted a cash-flow positive Q3 FY26 with a 125% jump in customer receipts and locked in landmark contracts with Banobras and Services Australia, underpinning its AI-driven compliance strategy.

Neuren Pharmaceuticals reported a 15% rise in 2025 royalties from DAYBUE®, boosted by strong US sales and a new powder formulation launch. The company is progressing its pivotal Phase 3 trial for NNZ-2591 in Phelan-McDermid syndrome and reassessing capital management amid solid cash reserves.